WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients

WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients

Platinum-based chemotherapy toxicity is always one of the serious problems from which lung cancer patients suffer. The genetic polymorphism of WISP1 was revealed to be associated with susceptibility and platinum-based chemotherapy response in our previous studies. In this study, we aimed to investi...

Full description

Bibliographic Details
Main Authors: Juan Chen, Jiye Yin, Xiangping Li, Ying Wang, Yi Zheng, Chenyue Qian, Ling Xiao, Ting Zou, Zhan Wang, Junyan Liu, Wei Zhang, Honghao Zhou, Zhaoqian Liu
Format: Article
Language:English
Published: MDPI AG 2014-11-01
Series:International Journal of Molecular Sciences
Subjects:
WISP1
lung cancer
genetic polymorphism
chemotherapy toxicity
Online Access:http://www.mdpi.com/1422-0067/15/11/21011

Internet

http://www.mdpi.com/1422-0067/15/11/21011

Similar Items